Bioactive testosterone refers to the fraction of total testosterone circulating in the blood that is not tightly bound to Sex Hormone-Binding Globulin (SHBG), meaning it is free or loosely bound to albumin, making it immediately available to interact with androgen receptors in target tissues. This measurement is clinically superior for assessing androgenic effects compared to total testosterone levels alone. It represents the physiologically relevant pool of the hormone.
Origin
The term merges ‘testosterone,’ the primary androgen produced in the gonads, with ‘bioactive,’ signifying the subset of the molecule capable of eliciting a measurable biological response upon receptor engagement. This distinction became necessary as endocrine assessment evolved beyond simple bulk measurement.
Mechanism
Bioactive testosterone achieves its effect by diffusing across the plasma membrane of target cells, such as muscle or prostate cells, and binding to the intracellular androgen receptor. This receptor-ligand complex then translocates to the nucleus to modulate gene expression related to anabolism or secondary sexual characteristics. The unbound state allows for this rapid and direct interaction with nuclear machinery.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.